Smith & Wesson Brands (SWBI) SWBI Q4 Financial Results Summary
· Stocks · QuoteReporter
Smith & Wesson Brands, Inc. (SWBI) Q4 2026: Strong Revenue Growth and Improved Profitability — Positive Outlook
Smith & Wesson Brands, Inc. (NASDAQ: SWBI) reported its fourth quarter financial results for fiscal 2026, showcasing a significant improvement in both revenue and profitability compared to the prior year.
Key Findings
- Net Sales: Q4 net sales reached $178.4 million, an increase of $37.6 million, or 26.7% year-over-year.
- Gross Margin: The gross margin improved to 29.8%, up from 28.8% in the same quarter last year.
- Earnings Per Share (EPS): The company reported a Q4 EPS of $0.36, compared to $0.19 in the prior year, reflecting a substantial increase in profitability.
- Cash from Operations: Cash generated from operations was $74.6 million.
Analyst Opinion
This quarter represents a strong performance for Smith & Wesson, with significant revenue growth and improved margins indicating effective management and operational efficiency. The increase in net sales by 26.7% and the rise in EPS to $0.36 are particularly noteworthy, as they demonstrate the company's ability to capitalize on market demand and enhance profitability. This is a positive quarter for shareholders, as the results not only exceed the previous year's performance but also reflect a robust operational strategy.
Detailed Metrics
- Net Sales:
- Q4 2026: $178.4 million
- Q4 2025: $140.8 million
- Year-over-Year Growth: $37.6 million or 26.7%
- Gross Margin:
- Q4 2026: 29.8%
- Q4 2025: 28.8%
- GAAP Net Income:
- Q4 2026: $16.2 million or $0.36 per diluted share
- Q4 2025: $8.6 million or $0.19 per diluted share
- Non-GAAP Net Income:
- Q4 2026: $16.2 million or $0.36 per diluted share
- Q4 2025: $9.0 million or $0.20 per diluted share
- Non-GAAP Adjusted EBITDAS:
- Q4 2026: $30.9 million or 17.3% of net sales
- Q4 2025: $23.5 million or 16.7% of net sales
Dividend and Shareholder Returns
Smith & Wesson announced a quarterly dividend of $0.13 per share, which will be paid to stockholders of record on July 1, 2026, with payment on July 15, 2026. This consistent dividend payment, which totaled $23.2 million for the fiscal year, reflects the company's commitment to returning value to its shareholders.
Debt Management
The company also made strides in debt reduction, repaying $60.0 million on its revolving credit facility during the fiscal year. This proactive approach to managing debt enhances the company's financial stability and positions it well for future growth.
Forward-Looking Catalysts
Looking ahead, investors should monitor the company's performance in fiscal 2027, particularly in light of management's expectation for continued healthy demand in the firearm industry. The introduction of new products, which accounted for 37.5% of total revenue in Q4, will be crucial in sustaining growth. Additionally, the company's strategic focus on expanding its market presence and improving operational efficiencies will be key drivers to watch in the upcoming quarters.
In conclusion, Smith & Wesson's Q4 results reflect a strong operational performance and a positive outlook for the future, making it an attractive proposition for investors looking for growth in the firearm manufacturing sector.
Note: The following tables are in thousands.
| For the | Three Months Ended April 30, 2026 | Year Ended April 30, 2025 | Year Ended April 30, 2026 |
|---|---|---|---|
| Net sales | $ 178,388 | $ 140,762 | $ 523,845 |
| Cost of sales | 125,298 | 100,217 | 382,742 |
| Gross profit | 53,090 | 40,545 | 141,103 |
| Operating expenses | |||
| Research and development expenses | 2,452 | 1,962 | 10,304 |
| Selling, marketing and distribution expenses | 11,339 | 11,474 | 41,598 |
| General and administrative expenses | 17,736 | 13,973 | 59,999 |
| Gain on sale/disposition of assets, net | 222 | 6 | (9) |
| Total operating expenses | 31,749 | 27,415 | 111,892 |
| Operating income | 21,341 | 13,130 | 29,211 |
| Other expenses, net: | |||
| Other income, net | 146 | (6) | 669 |
| Interest expense, net | (693) | (748) | (4,810) |
| Total other expenses, net | (547) | (754) | (4,141) |
| Income before income taxes | 20,794 | 12,376 | 25,070 |
| Income tax expense | 4,572 | 3,742 | 6,589 |
| Net income | $ 16,222 | $ 8,634 | $ 18,481 |
| Net income per share: | |||
| Basic - net income | $ 0.36 | $ 0.20 | $ 0.42 |
| Diluted - net income | $ 0.36 | $ 0.19 | $ 0.41 |
| Weighted-average number of common shares outstanding | |||
| Basic | 44,533 | 44,040 | 44,420 |
| Diluted | 45,262 | 44,508 | 44,933 |
| As of: | April 30, 2026 | April 30, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 28,190 | $ 25,231 |
| Marketable securities | 5,162 | — |
| Accounts receivable, net of allowances for credit losses of $5 on April 30, 2026 and April 30, 2025 | 40,014 | 55,868 |
| Inventories | 156,250 | 189,840 |
| Prepaid expenses and other current assets | 7,170 | 6,260 |
| Income tax receivable | 4,617 | 66 |
| Total current assets | 241,403 | 277,265 |
| Property, plant, and equipment, net of accumulated depreciation and amortization of $397,668 on April 30, 2026 and $368,811 on April 30, 2025 | 238,643 | 242,648 |
| Intangibles, net | 1,956 | 2,409 |
| Goodwill | 19,024 | 19,024 |
| Deferred income taxes | 4,347 | 10,260 |
| Other assets | 7,393 | 8,006 |
| Total assets | $ 512,766 | $ 559,612 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $ 34,570 | $ 26,887 |
| Accrued expenses and deferred revenue | 19,146 | 24,678 |
| Accrued payroll and incentives | 15,196 | 9,060 |
| Accrued profit sharing | 5,155 | 4,636 |
| Accrued warranty | 1,300 | 1,379 |
| Total current liabilities | 75,367 | 66,640 |
| Notes and loans payable | 19,121 | 79,096 |
| Finance lease payable, net of current portion | 32,163 | 33,703 |
| Other non-current liabilities | 9,556 | 7,719 |
| Total liabilities | 136,207 | 187,158 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 20,000,000 shares authorized, no shares issued or outstanding | — | — |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 44,605,993 shares issued and outstanding on April 30, 2026 and 75,789,455 shares issued and 44,111,461 shares outstanding on April 30, 2025 | 45 | 76 |
| Additional paid-in capital | 2,776 | 298,075 |
| Retained earnings | 373,738 | 532,615 |
| Treasury stock, at cost (no shares on April 30, 2026 and 31,677,994 shares on April 30, 2025) | — | (458,312) |
| Total stockholders’ equity | 376,559 | 372,454 |
| Total liabilities and stockholders’ equity | $ 512,766 | $ 559,612 |
Disclaimer
The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.